Dakota Cancer Institute

Fargo, North Dakota 58108-6001

0 studies enrolling now · 21 studies all time

What they study most

Brain Tumor, Brain and Central Nervous System Tumors, Carcinoma, Non-Small-Cell Lung, Catheter Occlusion, Central Nervous System Tumor, Fever, Sweats, and Hot Flashes, Kidney Cancer, Leukemia, Lymphoma, Multiple Myeloma, Neuroblastoma, Neutropenia

Studies at this site

• Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer — Completed
• Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma — Completed
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Hodgkin's or Non-Hodgkin's Lymphoma — Completed
• Vinorelbine in Treating Children With Recurrent or Refractory Cancers — Completed
• Chemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney Tumors — Completed
• Chemotherapy in Treating Children With Recurrent Acute Myeloid Leukemia — Completed
• STI571 in Treating Patients With Recurrent Leukemia — Completed
• Gemcitabine in Treating Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia — Completed
• Antibiotic Therapy With or Without G-CSF in Treating Children With Neutropenia and Fever Caused by Chemotherapy — Completed
• Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Glioma — Completed
• Lobradimil and Carboplatin in Treating Children With Brain Tumors — Completed
• Chemotherapy in Treating Children With Recurrent or Refractory Sarcomas — Completed
• Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma — Completed
• TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian Cancer — Completed
• Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer — Completed
• TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer — Completed
• Expanded Access Program:Lenalidomide With or Without Dexamethasone In Previously Treated Subjects With Multiple Myeloma — Completed
• GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer — Stopped early
• Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Catheters — Completed
• Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer — Completed
• DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2]) — Stopped early